Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3108)
Zymeworks Inc. (ZYME)
Schayowitz Adam — EVP, Head of R&D
Shares
13,832
Price
$25.85
Total Value
$357.56K
Shares Held After
23,205
% of Holdings
37.3%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
36,209
Price
$95.37
Total Value
$3.45M
Shares Held After
0
% of Holdings
100.0%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
27,000
Price
$92.31
Total Value
$2.49M
Shares Held After
36,209
% of Holdings
42.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$541.23
Total Value
$21.65K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
424
Price
$540.51
Total Value
$229.18K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$539.58
Total Value
$588.68K
Shares Held After
324,907
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
605
Price
$538.60
Total Value
$325.85K
Shares Held After
325,998
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,016
Price
$537.53
Total Value
$546.13K
Shares Held After
326,603
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$536.61
Total Value
$442.16K
Shares Held After
327,619
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$535.46
Total Value
$257.02K
Shares Held After
328,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$534.28
Total Value
$491.54K
Shares Held After
328,923
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$533.36
Total Value
$426.69K
Shares Held After
329,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$532.07
Total Value
$319.24K
Shares Held After
330,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,061
Price
$531.07
Total Value
$563.47K
Shares Held After
331,243
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
199
Price
$530.13
Total Value
$105.50K
Shares Held After
332,304
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$528.63
Total Value
$105.73K
Shares Held After
332,503
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
273
Price
$527.57
Total Value
$144.03K
Shares Held After
332,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
767
Price
$526.66
Total Value
$403.95K
Shares Held After
332,976
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$525.50
Total Value
$105.10K
Shares Held After
333,743
% of Holdings
0.1%
UroGen Pharma Ltd. (URGN)
Degnan Chris — Chief Financial Officer
Shares
2,202
Price
$36.69
Total Value
$80.79K
Shares Held After
4,561
% of Holdings
32.6%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
90,000
Price
$8.57
Total Value
$770.90K
Shares Held After
529,000
% of Holdings
17.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
200
Price
$110.51
Total Value
$22.10K
Shares Held After
767,780
% of Holdings
0.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
11,900
Price
$110.00
Total Value
$1.31M
Shares Held After
767,980
% of Holdings
1.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,090
Price
$108.91
Total Value
$336.53K
Shares Held After
779,880
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,810
Price
$108.18
Total Value
$520.34K
Shares Held After
782,970
% of Holdings
0.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$25.66
Total Value
$304.87K
Shares Held After
377,802
% of Holdings
3.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
2,256
Price
$1.33
Total Value
$3.00K
Shares Held After
945,924
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
268
Price
$4.84
Total Value
$1.30K
Shares Held After
227,604
% of Holdings
0.1%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
328
Price
$4.84
Total Value
$1.59K
Shares Held After
199,673
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
1,937
Price
$4.84
Total Value
$9.38K
Shares Held After
9,530
% of Holdings
20.3%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
53
Price
$63.95
Total Value
$3.39K
Shares Held After
1,294,094
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,447
Price
$63.38
Total Value
$155.09K
Shares Held After
1,294,147
% of Holdings
0.2%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
1,327
Price
$32.06
Total Value
$42.54K
Shares Held After
175,218
% of Holdings
0.8%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
2,241
Price
$32.06
Total Value
$71.85K
Shares Held After
217,060
% of Holdings
1.0%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,596
Price
$32.06
Total Value
$51.17K
Shares Held After
201,532
% of Holdings
0.8%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,213
Price
$32.06
Total Value
$70.95K
Shares Held After
203,128
% of Holdings
1.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
125,000
Price
$8.40
Total Value
$1.05M
Shares Held After
439,000
% of Holdings
28.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
200
Price
$113.69
Total Value
$22.74K
Shares Held After
767,780
% of Holdings
0.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
900
Price
$112.78
Total Value
$101.50K
Shares Held After
767,980
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
10,300
Price
$111.84
Total Value
$1.15M
Shares Held After
768,880
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
8,600
Price
$111.03
Total Value
$954.87K
Shares Held After
779,180
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$26.40
Total Value
$313.66K
Shares Held After
377,802
% of Holdings
3.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,046
Price
$1.33
Total Value
$4.05K
Shares Held After
943,668
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$556.48
Total Value
$222.59K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
930
Price
$555.77
Total Value
$516.87K
Shares Held After
324,843
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$554.51
Total Value
$268.94K
Shares Held After
325,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
185
Price
$553.70
Total Value
$102.43K
Shares Held After
326,258
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$552.29
Total Value
$243.01K
Shares Held After
326,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
486
Price
$551.09
Total Value
$267.83K
Shares Held After
326,883
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
874
Price
$550.14
Total Value
$480.82K
Shares Held After
327,369
% of Holdings
0.3%
Showing 1–50 of 3108 transactions (page 1 of 63)